Clinical trials
Active, not recruiting Phase 3 Myelodysplastic Syndromes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Children's Oncology Group | 2 |
| AbbVie | 1 |
| Celgene | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| GWT-TUD GmbH | 1 |
| Groupe Francophone des Myelodysplasies | 1 |
| National Cancer Institute (NCI) | 1 |
| Orca Biosystems, Inc. | 1 |
| Otsuka Australia Pharmaceutical Pty Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 12 |
| Anemia | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Leukemia, Biphenotypic, Acute | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Down Syndrome | 1 |
| Leukemia, Myelomonocytic, Acute | 1 |
| Leukemia, Myelomonocytic, Juvenile | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.